Total Voting Rights

RNS Number : 6243A
BlueRock Diamonds PLC
31 May 2019
 

 

BlueRock Diamonds plc

("BlueRock" or the "Company")

Total Voting Rights

31 May 2019

In accordance with the Financial Conduct Authority's Disclosure and Transparency Rules, BlueRock Diamonds hereby announces that it has 1,629,001,910 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company is 1,629,001,910.

The above figure of 1,629,001,910 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

**ENDS**

For further information, please visit BlueRock's website www.bluerockdiamonds.co.uk or contact:

 

BlueRock Diamonds PLC

David Facey, FD

Mike Houston, Executive Chairman

 

 

dfacey@bluerockdiamonds.co.uk

mhouston@bluerockdiamonds.co.uk

SP Angel (NOMAD and Broker)

Stuart Gledhill / Caroline Rowe

 

Tel: +44 (0)20 3470 0470

SVS Securities Limited

Tom Curran/Ben Tadd

Tel +44 (0)20 3700 0093

St Brides Partners Ltd (Financial PR)

Melissa Hancock / Juliet Earl

 

Tel: +44 (0)20 7236 1177

 

Notes to editors:

BlueRock Diamonds is an AIM-listed diamond producer which operates the Kareevlei Diamond Mine near Kimberley in South Africa which produces diamonds of exceptional quality and ranks in the top ten in the world in terms of average value per carat. The Kareevlei licence area covers 3,000 hectares and hosts five known diamondiferous kimberlite pipes.  As at November 2018, it was estimated that the remaining Inferred Mineral Resource from the four kimberlite pipes (KV1, KV2, KV3 and KV5) represents a potential inground number of carats of 367,000.

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVREAESEDAENEFF
UK 100

Latest directors dealings